Product Code: MD 9121
The global blood pressure cuffs market is projected to reach USD 1.3 billion by 2032 from USD 0.7 billion in 2025, at a CAGR of 9.0% during the forecast period.
Scope of the Report |
Years Considered for the Study | 2023-2032 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Type, Size, Usage, Age Group, Distribution Channel, End User, and Region |
Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
The increasing global burden of chronic non-communicable diseases, including hypertension, obesity, and cardiovascular disorders, primarily drives the expansion of the blood pressure monitoring market. These conditions significantly increase blood pressure levels, necessitating consistent monitoring and management. Moreover, heightened public and clinical awareness of hypertension and its associated complications has led to greater demand for effective diagnostic and monitoring solutions. Concurrently, market growth is further supported by continuous technological advancements and product innovation by key industry players. These developments include introducing non-invasive, automated, and wearable blood pressure monitoring devices to improve accuracy, usability, and patient compliance.
By type, the automated segment accounted for the largest market share in 2024.
By type, the blood pressure cuffs market is segmented into automated and manual segments. The automated blood pressure cuffs segment accounted for the largest market share in 2024. The automated blood pressure cuffs are widely used in clinical environments for routine check-ups and 24-hour ambulatory monitoring, providing continuous and accurate readings. These devices are favored for their user-friendly design, digital displays, and ability to deliver consistent measurements without requiring specialized training. The growing prevalence of hypertension worldwide, driven by aging populations, poor dietary habits, and increased stress, has significantly boosted the demand for automated monitoring solutions.
By usage, the reusable segment accounted for the largest market share in 2024.
By usage, the blood pressure cuffs market into reusable and disposable types. The reusable blood pressure cuffs segment accounted for the largest market share in 2024. The large share of this segment is attributed to the cost-effectiveness in large healthcare facilities such as hospitals, nursing homes, and clinics, where devices are used frequently. These institutions benefit from the long-term savings associated with reduced replacement needs compared to single-use cuffs. Growing environmental concerns have also led to increased initiatives to minimize medical waste, encouraging the shift towards sustainable and eco-friendly healthcare practices. Regulatory bodies and healthcare organizations also introduce policies and guidelines that favor adopting reusable medical products, further supporting their widespread use.
By region, the Asia Pacific region is projected to grow at the highest CAGR during the forecast period.
The global blood pressure cuffs market is divided into five key regions: North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. The Asia Pacific region, which includes countries like Japan, India, China, Australia, South Korea, and others, is expected to grow at the highest CAGR during the forecast period. Several factors contribute to this growth in the Asia Pacific, including rising government initiatives promoting early disease detection and routine health screenings, increasing healthcare expenditures, and expanding hospital networks and diagnostic laboratories. Additionally, the growing patient awareness and the awareness of blood pressure monitoring is fueling market growth.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-40%, Tier 2-50%, and Tier 3- 10%
- By Designation: C-level-48%, Director-level-37%, and Others-15%
- By Region: North America-46%, Europe-26%, Asia Pacific-17%, Latin America- 7%, and the Middle East and Africa - 5%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The leading players operating in the blood pressure cuffs market are OMRON Corporation, Inc. (Japan), Baxter International Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (US), McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (UK), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Microlife Corporation (Switzerland), BIOS Medical (UK), ACCOSON (UK), Midmark Corporation (US), and Beurer GmbH (Germany).
Research Coverage
This report segments the global blood pressure cuffs market based on various criteria: type (automated and manual), size (infants to young adults (8-25 cm), adults to long adults (26-34cm), large to extra-large adults (35-50cm), usage (reusable and disposable), age group (adults and infants & children), distribution channel (healthcare facilities, retail pharmacies, and online pharmacies), end user (hospitals, homecare settings, ambulatory care centers, urgent care centers, primary centers, and other end users), and region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa).
The report analyzes the key drivers, challenges, opportunities, and restraints influencing market growth. It also offers a detailed evaluation of leading industry players, covering their business profiles, service portfolios, strategic initiatives, partnerships, acquisitions, and recent blood pressure cuffs market developments. Furthermore, the report explores the competitive dynamics of emerging startups within the blood pressure cuffs ecosystem.
Reasons to Buy the Report
The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (increasing geriatric population and subsequent increase in CVD and hypertension, high incidence of HAIs to fuel adoption of single-use pressure cuffs), restraints (availability of alternative methods and devices for monitoring blood pressure), opportunities (rising technological advancements in blood pressure monitors, growing demand for telehealth & remote patient monitoring services), and challenges (miscuffing challenges, technical limitations, and accuracy issues, issues with manual errors, low awareness regarding hypertension)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the blood pressure cuffs market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the blood pressure cuffs market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the blood pressure cuffs market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 YEARS CONSIDERED
- 1.3.3 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Primary sources
- 2.1.2.2 Key industry insights
- 2.1.2.3 Key data from primary sources
- 2.1.2.4 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Approach 1: Company revenue estimation approach
- 2.2.1.2 Approach 2: Presentations of companies & primary interviews
- 2.2.1.3 Approach 3: Primary interviews
- 2.2.1.4 Approach 4: Growth Forecast
- 2.2.1.5 CAGR projections
- 2.2.2 TOP-DOWN APPROACH
- 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.4 RESEARCH ASSUMPTIONS
- 2.4.1 STUDY-RELATED ASSUMPTIONS
- 2.4.2 GROWTH RATE ASSUMPTIONS
- 2.5 RISK ASSESSMENT
- 2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 BLOOD PRESSURE CUFFS MARKET OVERVIEW
- 4.2 ASIA PACIFIC: BLOOD PRESSURE CUFFS MARKET, BY TYPE & COUNTRY (2024)
- 4.3 BLOOD PRESSURE CUFFS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.4 BLOOD PRESSURE CUFFS MARKET: REGIONAL MIX (2025-2032)
- 4.5 BLOOD PRESSURE CUFFS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing geriatric population and subsequent rise in CVD and hypertension
- 5.2.1.2 High incidence of HAIs to fuel adoption of single-use pressure cuffs
- 5.2.2 RESTRAINTS
- 5.2.2.1 Availability of alternative methods & devices for monitoring blood pressure
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising technological advancements in blood pressure monitors
- 5.2.3.2 Growing demand for telehealth & remote patient monitoring services
- 5.2.4 CHALLENGES
- 5.2.4.1 Miscuffing challenges
- 5.2.4.2 Technical limitations and accuracy issues
- 5.2.4.3 Issues with manual errors
- 5.2.4.4 Low awareness regarding hypertension
- 5.3 INDUSTRY TRENDS
- 5.3.1 ADOPTION OF REUSABLE BLOOD PRESSURE CUFFS FOR INFECTION CONTROL MEASURES
- 5.3.2 ADVANCEMENTS IN WEARABLE BLOOD PRESSURE MONITORING DEVICES
- 5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
- 5.4.2.1 Auscultatory techniques
- 5.4.3 ADJACENT TECHNOLOGIES
- 5.4.3.1 Palpatory technique
- 5.5 PORTER'S FIVE FORCES ANALYSIS
- 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.5.2 BARGAINING POWER OF SUPPLIERS
- 5.5.3 BARGAINING POWER OF BUYERS
- 5.5.4 THREAT OF NEW ENTRANTS
- 5.5.5 THREAT OF SUBSTITUTES
- 5.6 REGULATORY LANDSCAPE
- 5.6.1 REGULATORY ANALYSIS
- 5.6.1.1 North America
- 5.6.1.1.1 US
- 5.6.1.1.2 Canada
- 5.6.1.2 Europe
- 5.6.1.2.1 Germany
- 5.6.1.2.2 UK
- 5.6.1.3 Asia Pacific
- 5.6.1.3.1 China
- 5.6.1.3.2 Japan
- 5.6.1.3.3 India
- 5.6.1.4 Australia
- 5.6.1.5 Latin America
- 5.6.1.6 Middle East
- 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.6.2.1 North America
- 5.6.2.2 Europe
- 5.6.2.3 Asia Pacific
- 5.6.2.4 Latin America
- 5.6.2.5 Rest of the World
- 5.7 PATENT ANALYSIS
- 5.8 TRADE ANALYSIS
- 5.8.1 IMPORT DATA (HS CODE 901890)
- 5.8.2 EXPORT DATA (HS CODE 901890)
- 5.9 PRICING ANALYSIS
- 5.9.1 AVERAGE SELLING PRICE TREND, BY TYPE, 2023-2025
- 5.9.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
- 5.9.3 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
- 5.10 REIMBURSEMENT ANALYSIS
- 5.11 KEY CONFERENCES & EVENTS, 2025-2026
- 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.12.2 BUYING CRITERIA
- 5.13 UNMET NEEDS/END-USER EXPECTATIONS
- 5.14 VALUE CHAIN ANALYSIS
- 5.15 SUPPLY CHAIN ANALYSIS
- 5.16 IMPACT OF AI/GENERATIVE AI ON BLOOD PRESSURE CUFFS MARKET
- 5.16.1 INTRODUCTION
- 5.16.2 MARKET POTENTIAL OF AI ON BLOOD PRESSURE CUFFS MARKET
- 5.16.3 AI USE CASES
- 5.16.4 KEY COMPANIES IMPLEMENTING AI
- 5.16.5 FUTURE OF AI IN BLOOD PRESSURE CUFFS MARKET
- 5.17 ECOSYSTEM ANALYSIS
- 5.18 CASE STUDY ANALYSIS
- 5.18.1 CASE STUDY 1: EFFECTS OF CUFF SIZE ON ACCURACY OF BLOOD PRESSURE READINGS
- 5.18.2 CASE STUDY 2: BLOOD PRESSURE CUFFS COLONIZED BY BACTERIAL DIVERSITY
- 5.18.3 CASE STUDY 3: IMPLEMENTATION OF REMOTE MONITORING PROTOCOL FOR HIGH-RISK PATIENTS
- 5.19 ADJACENT MARKETS FOR BLOOD PRESSURE CUFFS MARKET
- 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.21 INVESTMENT & FUNDING SCENARIO
- 5.22 TRUMP TARIFF IMPACT ON BLOOD PRESSURE CUFFS MARKET
- 5.22.1 INTRODUCTION
- 5.22.2 KEY TARIFF RATES
- 5.22.3 PRICE IMPACT ANALYSIS
- 5.22.4 KEY IMPACTS ON COUNTRY/REGION
- 5.22.4.1 North America
- 5.22.4.2 Europe
- 5.22.4.3 Asia Pacific
- 5.22.5 IMPACT ON END-USE INDUSTRIES
- 5.22.5.1 Hospitals & ASCs
6 BLOOD PRESSURE CUFFS MARKET, BY TYPE
- 6.1 INTRODUCTION
- 6.2 AUTOMATED BLOOD PRESSURE CUFFS
- 6.2.1 RISING TECHNOLOGICAL ADVANCEMENTS AND CONVENIENCE IN OUTPATIENT SETTINGS TO BOOST DEMAND
- 6.3 MANUAL BLOOD PRESSURE CUFFS
- 6.3.1 STANDARD ACCESSIBILITY ACROSS HEALTHCARE FACILITIES TO SUSTAIN MARKET GROWTH
7 BLOOD PRESSURE CUFFS MARKET, BY SIZE
- 7.1 INTRODUCTION
- 7.2 INFANTS TO YOUNG ADULTS (8-25CM)
- 7.2.1 INCREASING PREVALENCE OF NEONATAL DISORDERS TO FUEL UPTAKE
- 7.3 ADULTS TO LONG ADULTS (26-34 CM)
- 7.3.1 RISING INCIDENCE OF HYPERTENSION AND GROWING FOCUS ON PATIENT MONITORING TO DRIVE MARKET
- 7.4 LARGE TO EXTRA-LARGE ADULTS (35-50 CM)
- 7.4.1 INCREASING CASES OF OBESITY AND CVD TO SUPPORT MARKET GROWTH
8 BLOOD PRESSURE CUFFS MARKET, BY USAGE
- 8.1 INTRODUCTION
- 8.2 REUSABLE BLOOD PRESSURE CUFFS
- 8.2.1 LOW COST AND HIGH DURABILITY TO BOOST DEMAND
- 8.3 DISPOSABLE BLOOD PRESSURE CUFFS
- 8.3.1 GROWING NEED TO REDUCE TRANSMISSION OF HAIS TO FUEL UPTAKE
9 BLOOD PRESSURE CUFFS MARKET, BY AGE GROUP
- 9.1 INTRODUCTION
- 9.2 ADULTS
- 9.2.1 GROWING FOCUS ON EARLY DISEASE DIAGNOSIS TO PROPEL MARKET
- 9.3 INFANTS & CHILDREN
- 9.3.1 INCREASING CASES OF NEONATAL HYPERTENSION TO BOOST DEMAND
10 BLOOD PRESSURE CUFFS MARKET, BY DISTRIBUTION CHANNEL
- 10.1 INTRODUCTION
- 10.2 HEALTHCARE FACILITIES
- 10.2.1 HIGH PROCUREMENT ACROSS HEALTH AGENCIES TO BOOST DEMAND
- 10.3 RETAIL PHARMACIES
- 10.3.1 GROWING ACCESSIBILITY IN UNDERSERVED AREAS TO AID MARKET
- 10.4 ONLINE PHARMACIES
- 10.4.1 LOW COSTS AND REMOTE CONVENIENCE TO PROPEL MARKET
11 BLOOD PRESSURE CUFFS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 HOSPITALS
- 11.2.1 HIGH PURCHASING POWER FOR INSTALLATION & MAINTENANCE COSTS TO PROPEL MARKET
- 11.3 HOME CARE SETTINGS
- 11.3.1 GROWING ACCESSIBILITY TO ADVANCED DEVICES OUTSIDE CLINICAL SETTINGS TO DRIVE MARKET
- 11.4 AMBULATORY CARE CENTERS
- 11.4.1 COST-EFFICIENT OUTPATIENT INFRASTRUCTURE TO BOOST DEMAND
- 11.5 URGENT CARE CENTERS
- 11.5.1 EXPANDING ACCESS TO CRITICAL CARE TO SUPPORT MARKET GROWTH
- 11.6 PRIMARY CENTERS
- 11.6.1 GROWING FOCUS ON CHRONIC DISEASE MANAGEMENT TO FUEL UPTAKE
- 11.7 OTHER END USERS
12 BLOOD PRESSURE CUFFS MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 12.2.2 US
- 12.2.2.1 High healthcare expenditure and adoption of technologically advanced devices to fuel uptake
- 12.2.3 CANADA
- 12.2.3.1 Rising cases of obesity & CVD to drive market
- 12.3 EUROPE
- 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 12.3.2 GERMANY
- 12.3.2.1 Established healthcare system and stringent regulations for medical devices industry to fuel market
- 12.3.3 UK
- 12.3.3.1 Favorable public-private investments in healthcare technologies to aid market
- 12.3.4 FRANCE
- 12.3.4.1 Increasing demand for age-monitoring healthcare solutions to fuel market
- 12.3.5 ITALY
- 12.3.5.1 Rising cases of CVD to support market growth
- 12.3.6 SPAIN
- 12.3.6.1 Growing demand for improved diagnostic accuracy to fuel uptake
- 12.3.7 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 12.4.2 JAPAN
- 12.4.2.1 Expanding geriatric population and subsequent rise in chronic diseases to propel market
- 12.4.3 CHINA
- 12.4.3.1 Rising establishment of hospitals and surge in infectious diseases to drive market
- 12.4.4 INDIA
- 12.4.4.1 Infrastructural improvements and increasing incidence of target conditions to fuel market
- 12.4.5 AUSTRALIA
- 12.4.5.1 Expanding healthcare facilities and increasing prevalence of hypertension to boost demand
- 12.4.6 SOUTH KOREA
- 12.4.6.1 High adoption of technological advancements in monitoring devices to support market growth
- 12.4.7 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 12.5.2 BRAZIL
- 12.5.2.1 Shortage of healthcare professionals and growing focus on remote patient monitoring to drive market
- 12.5.3 MEXICO
- 12.5.3.1 High mortality rate for CVD to boost demand
- 12.5.4 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 GCC COUNTRIES
- 12.6.1.1 Kingdom of Saudi Arabia (KSA)
- 12.6.1.1.1 Rising focus on technological innovation to support market growth
- 12.6.1.2 United Arab Emirates (UAE)
- 12.6.1.2.1 Promotion of telemedicine to fuel uptake
- 12.6.1.3 Other GCC Countries
- 12.6.2 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
- 13.1 OVERVIEW
- 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.3 REVENUE ANALYSIS, 2022-2024
- 13.4 MARKET SHARE ANALYSIS, 2024
- 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 13.5.5.1 Company footprint
- 13.5.5.2 Region footprint
- 13.5.5.3 Usage footprint
- 13.5.5.4 Age-group footprint
- 13.5.5.5 End-user footprint
- 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 13.6.5.1 List of key startups/SMEs
- 13.7 COMPANY VALUATION & FINANCIAL METRICS
- 13.7.1 FINANCIAL METRICS
- 13.7.2 COMPANY VALUATION
- 13.8 BRAND/PRODUCT COMPARISON ANALYSIS
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 DEALS
- 13.9.2 EXPANSIONS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 OMRON CORPORATION
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 Recent developments
- 14.1.1.3.1 Deals
- 14.1.1.3.2 Expansions
- 14.1.1.3.3 Other developments
- 14.1.1.4 MnM view
- 14.1.1.4.1 Key strengths
- 14.1.1.4.2 Strategic choices
- 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 BAXTER INTERNATIONAL, INC.
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.3 Recent developments
- 14.1.2.3.1 Expansions
- 14.1.2.3.2 Other developments
- 14.1.2.4 MnM view
- 14.1.2.4.1 Key strengths
- 14.1.2.4.2 Strategic choices
- 14.1.2.4.3 Weaknesses & competitive threats
- 14.1.3 KONINKLIJKE PHILIPS N.V.
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 MnM view
- 14.1.3.3.1 Key strengths
- 14.1.3.3.2 Strategic choices
- 14.1.3.3.3 Weaknesses & competitive threats
- 14.1.4 GE HEALTHCARE TECHNOLOGIES INC.
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.4.3 Recent developments
- 14.1.5 MCKESSON CORPORATION
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.5.3 Recent developments
- 14.1.5.3.1 Other developments
- 14.1.6 B. BRAUN MELSUNGEN AG
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.7 HALMA PLC
- 14.1.7.1 Business overview
- 14.1.7.2 Products offered
- 14.1.7.3 Recent developments
- 14.1.8 OSI SYSTEMS, INC.
- 14.1.8.1 Business overview
- 14.1.8.2 Products offered
- 14.1.9 AMERICAN DIAGNOSTIC CORPORATION
- 14.1.9.1 Business overview
- 14.1.9.2 Products offered
- 14.1.10 MEDLINE INDUSTRIES, LP.
- 14.1.10.1 Business overview
- 14.1.10.2 Products offered
- 14.1.10.3 Recent developments
- 14.1.11 MICROLIFE CORPORATION
- 14.1.11.1 Business overview
- 14.1.11.2 Products offered
- 14.1.12 BIOS MEDICAL
- 14.1.12.1 Business overview
- 14.1.12.2 Products offered
- 14.1.13 ACCOSON
- 14.1.13.1 Business overview
- 14.1.13.2 Products offered
- 14.1.14 MIDMARK CORPORATION
- 14.1.14.1 Business overview
- 14.1.14.2 Products offered
- 14.1.15 BEURER GMBH
- 14.1.15.1 Business overview
- 14.1.15.2 Products offered
- 14.2 OTHER PLAYERS
- 14.2.1 CELLBIOS
- 14.2.2 SOLARIS MEDICAL TECHNOLOGY, INC.
- 14.2.3 SPENGLER HOLTEX GROUP
- 14.2.4 TECHNICUFF
- 14.2.5 W.A. BAUM CO., INC.
- 14.2.6 BPL MEDICAL TECHNOLOGIES
- 14.2.7 BOEN HEALTHCARE CO., LTD.
- 14.2.8 MASIMO
- 14.2.9 F. BOSCH MEDIZINTECHNIK
- 14.2.10 MDF INSTRUMENTS
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS